Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003408539 | SCV004112737 | likely pathogenic | TBCD-related disorder | 2023-03-21 | criteria provided, single submitter | clinical testing | The TBCD c.2983delG variant is predicted to result in a frameshift and premature protein termination (p.Glu995Serfs*15). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-80887366-CG-C). Frameshift variants in TBCD are expected to be pathogenic. This variant is interpreted as likely pathogenic. |
Revvity Omics, |
RCV003492876 | SCV004238752 | likely pathogenic | Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome | 2023-03-06 | criteria provided, single submitter | clinical testing |